DC
BIVI icon

Diametric Capital’s BioVie BIVI Stock Holding History

Diametric Capital’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$498K Sell
256,636
-113,364
-31% -$178K 0.05% 331
2026
Q1 		$518K Hold
370,000
– – 0.13% 198
2025
Q4 		$429K Hold
370,000
– – 0.12% 263
2025
Q3 		$703K Buy
+370,000
New +$1.5M 0.26% 89

Other funds holding BIVI

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.56B AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Diametric Capital's BIVI Position: Q2 2026 in Review

Diametric Capital reduced its BioVie (BIVI) stake by 31% in Q2 2026, selling an estimated $178K and leaving 256,636 shares worth $498K. The position accounts for 0.05% of the portfolio, ranked #331.

Diametric Capital first reported a position in BIVI in Q3 2025 and has held it in 4 quarters since. The position peaked at $703K in Q3 2025. 36 funds tracked by Wall St. Rank hold BIVI as of Q2 2026.

  • Diametric Capital held 256,636 shares of BioVie worth $498K as of Q2 2026.
  • Diametric Capital sold 113,364 BioVie shares in Q2 2026, an estimated $178K.
  • BioVie made up 0.05% of Diametric Capital's portfolio in Q2 2026, its #331 holding.
  • Diametric Capital first reported a position in BioVie in Q3 2025 and has held it in 4 quarters since.
  • Diametric Capital's BioVie position peaked at $703K in Q3 2025.
  • 36 funds tracked by Wall St. Rank held BioVie as of Q2 2026.

Based on Diametric Capital's 13F filing for Q2 2026, filed 14 Aug 2026.